Company Financials

IDEAYA Biosciences, Inc. Financials

United States dollar

business IDEAYA Biosciences, Inc. Company Profile

Main Stock Listing

NASDAQ: IDYA

Market Capitalization $2.97 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -10.07
Forward PE -9.65
Price to Sales TTM $13.81
Price to Book MRQ $2.72
Enterprise to Revenue 10.28
Enterprise to EBITDA -10.70

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin -74.82%
Operating Margin 52.18%
Return on Assets TTM -10.77%
Return on Equity TTM -14.15%

Income Statement

Revenue TTM $214,834,000
Revenue per Share TTM $2.44
Quarterly Revenue Growth %
Gross Profit TTM $-153,454,000
EBITDA $-206,330,000
Net Income to Common TTM $-160,736,992
Diluted EPS TTM $-1.89
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ $786,894,016
Total Cash per Share MRQ $8.98
Total Debt MRQ $
Total Debt to Equity MRQ 2.50
Current Ratio MRQ 12.44
Book Value per Share MRQ $12.46

Cash Flow

Operating Cash Flow TTM $-102,257,000
Levered Free Cash Flow TTM $-65,895,624

IDYA Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 87,666,408
Float Shares 86,873,904
Avg 10 Volume 855,060
Avg 30 Volume None
Shares Short 7,223,004
Short Ratio 7.85
Short % of Shares 9.72%
% Held by Insiders 0.90%
% Held by Institutions 110.28%

Stock Price Summary

Beta 0.04
Fifty Two Week Low $13.45
Fifty Two Week High $37.08
Fifty Two Week Change 24.11%
Day 50 MA $33.18
Day 200 MA $24.86

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date